or Try an Advanced Search...

    Technical Analysis for NBTX - Nanobiotix S.A.

    Grade Last Price % Change Price Change
    F 3.80 -6.72% -0.27
    NBTX closed up 7.63 percent on Wednesday, November 20, 2024, on 1.58 times normal volume. The bears made the stock sink to a new 52-week low.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical NBTX trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup -6.72%
    Stochastic Buy Signal Bullish -6.72%
    New 52 Week Low Weakness -6.72%
    Outside Day Range Expansion -6.72%
    Lower Bollinger Band Touch Weakness -6.72%
    Oversold Stochastic Weakness -6.72%
    New 52 Week Closing Low Bearish 0.40%
    New 52 Week Low Weakness 0.40%
    Down 3 Days in a Row Weakness 0.40%
    Gapped Down Weakness 0.40%
    Older End-of-Day Signals for NBTX ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 2 hours ago
    Down 3% about 2 hours ago
    Down 2 % about 2 hours ago
    Fell Below 10 DMA about 2 hours ago
    Down 1% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NBTX Chart by TradingView
    Basic chart:

    Profile

    Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics to the heart of the cell. The Nanobiotix philosophy is rooted in designing pioneering, physical-based approaches to bring highly effective and generalized solutions to address unmet medical needs and challenges. Nanobiotix’s novel, proprietary lead technology, NBTXR3, aims to expand radiotherapy benefits for millions of cancer patients. Nanobiotix’s Immuno-Oncology program has the potential to bring a new dimension to cancer immunotherapies.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Clinical Medicine Immunotherapy Oncology Cancer Immunotherapy Virotherapy Immunotherapies Radiation Therapy Nanotechnology Nanomedicine Radiotherapy

    Is NBTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 12 Nanobiotix gives Q3 update
    Nov 12 NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
    Oct 31 NANOBIOTIX to Participate in Multiple Investor Conferences in November
    Sep 18 Nanobiotix reports 1H results
    Sep 18 NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
    Sep 4 NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
    Sep 3 Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Jun 12 NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
    Jun 11 Voting Rights and Shares Capital of the Company
    Jun 2 Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
    See more NBTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 8.962
    52 Week Low 3.5733
    Average Volume 9,375
    200-Day Moving Average 5.63
    50-Day Moving Average 4.70
    20-Day Moving Average 4.21
    10-Day Moving Average 4.01
    Average True Range 0.29
    RSI (14) 43.50
    ADX 19.82
    +DI 21.25
    -DI 23.09
    Chandelier Exit (Long, 3 ATRs) 4.20
    Chandelier Exit (Short, 3 ATRs) 4.44
    Upper Bollinger Bands 4.76
    Lower Bollinger Band 3.67
    Percent B (%b) 0.37
    BandWidth 25.70
    MACD Line -0.25
    MACD Signal Line -0.24
    MACD Histogram -0.0061
    Fundamentals Value
    Market Cap 191.67 Million
    Num Shares 47.1 Million
    EPS -1.81
    Price-to-Earnings (P/E) Ratio -2.25
    Price-to-Sales 51.51
    Price-to-Book 65.02
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.87
    Resistance 3 (R3) 4.80 4.45 4.74
    Resistance 2 (R2) 4.45 4.25 4.49 4.69
    Resistance 1 (R1) 4.26 4.12 4.36 4.34 4.65
    Pivot Point 3.92 3.92 3.97 3.96 3.92
    Support 1 (S1) 3.72 3.71 3.82 3.80 3.49
    Support 2 (S2) 3.38 3.59 3.42 3.44
    Support 3 (S3) 3.19 3.38 3.40
    Support 4 (S4) 3.26